Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,066.00
Bid: 3,089.00
Ask: 3,091.00
Change: 67.00 (2.23%)
Spread: 2.00 (0.065%)
Open: 3,047.00
High: 3,117.00
Low: 3,043.00
Prev. Close: 2,999.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and portfolio update

27 Jun 2024 07:00

RNS Number : 0455U
3i Group PLC
27 June 2024
 

 

 

 

27 June 2024

 

 

3i Group plc

AGM and portfolio update

 

 

3i Group plc ("3i") will be holding its Annual General Meeting ("AGM") this morning. At the AGM, Simon Borrows, our Chief Executive, will provide an update on the portfolio.

 

Action continues to perform strongly. Like-for-like sales growth was 9% year to date as at the end of week 25 and net new store openings of 107 are on track with its expansion plans and ahead of the 84 stores opened in the same period last year. The like-for-like performance is a combination of a high volume of transactions, driven specifically by the sale of everyday necessities, and a negative price effect. We believe Action's approach of passing on price reductions to consumers as a result of its growing buying power will continue to underpin its sector-leading like-for-like performance over the medium term. Action is set for another good quarter of profit growth and had a cash balance of €825 million as at 23 June 2024. Action has launched a €1.75 billion US dollar and euro debt issuance, which has since been upsized to €2.1 billion. We will update on the impact of that transaction and on the use of proceeds in our next quarterly statement.

 

The remainder of the Private Equity portfolio continues to demonstrate resilience with the majority of the portfolio trading well. The trends driving portfolio performance are consistent with those set out in our full-year results.

 

-Ends-

 

 

 

For further information, please contact:

Silvia SantoroGroup Investor Relations DirectorTel: 020 7975 3258

 

Kathryn van der KroftCommunications DirectorTel: 020 7975 3021

 

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMBRGDLLSDDGSL
Date   Source Headline
28th Jun 20243:01 pmRNSTotal Voting Rights
28th Jun 20242:25 pmRNSDirector/PDMR Shareholding
28th Jun 20241:47 pmRNSDirector/PDMR Shareholding
28th Jun 20248:06 amRNSDirector/PDMR Shareholding
27th Jun 20243:34 pmRNSDirector/PDMR Shareholding
27th Jun 20243:05 pmRNSDoc re. AGM Resolutions
27th Jun 20243:04 pmRNSResult of AGM
27th Jun 20242:23 pmRNSHolding(s) in Company
27th Jun 20247:00 amRNSAGM and portfolio update
25th Jun 20249:27 amRNSHolding(s) in Company
21st Jun 20241:55 pmRNSHolding(s) in Company
7th Jun 202411:17 amRNSBlock listing Interim Review
5th Jun 20246:01 pmRNSDirector/PDMR Shareholding
4th Jun 20249:19 amRNSDirector/PDMR Shareholding
3rd Jun 202412:42 pmRNSDirector/PDMR Shareholding
31st May 20244:58 pmRNSTotal Voting Rights
31st May 20244:57 pmRNSDirector/PDMR Shareholding
31st May 20244:55 pmRNSDirector/PDMR Shareholding
22nd May 20243:32 pmRNSDoc Re: 2024 Notice of AGM
16th May 20243:47 pmRNSDirector/PDMR Shareholding
16th May 20249:41 amRNSDoc re. 2024 Annual Report and Accounts
14th May 20242:43 pmRNSDirector/PDMR Shareholding
10th May 202411:47 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSResults for the year to 31 March 2024
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.